DRKS00016808已完成Unknown
INTENT_Circulating tumor cells as biomarkers for recurrence risk in thermoablation - INTENT
Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 100 人开始时间: 2023年2月21日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •a) treatment naïve HCC patients, BCLC 0 or A, maximum size of lesions <3cm
- •b) male/female, =18
- •c) indication for thermoablation
- •d) indication for TA according to multidisciplinary board decision
- •e) informed consent signed
排除标准
- •a) age <18
- •b) other pre-existing malignancies
- •c) contraindication for resection or thermoablation
- •d) life expectation < 3 months
研究者
相似试验
已完成
不适用
tudy on Biomarkers Using Circulating Tumor Cells When Administering Osimertinib in Patients with EGFR Mutation-positive Lung CancerJPRN-UMIN000032055Toho University50
撤回
不适用
Bio-marker Analysis Using Circulating Tumor Cells in Patients With MelanomaMelanomaNCT02828345Abramson Cancer Center at Penn Medicine
已完成
不适用
Circulating tumor cells as a diagnostic marker for pancreatico-biliary malignanciesPancreatico-biliary malignanciesJPRN-UMIN000029808Fukushima Medical University School of Medicine22
招募中
不适用
Clinical relevance of circulating tumor cells, ctDNA and diagnostic leukapheresis in pancreatic ductal adenocarcinoma patientsC25Malignant neoplasm of pancreasDRKS00023362niversitätsklinikum Hamburg-Eppendorf50
招募中
不适用
Circulating tumor cells to predict survival and monitor treatment response in patients with advanced HCCDRKS00029565Klinikum der Universität München, Campus Großhadern70